Chimeric antigen receptors (CARs) and their use in novel cancer therapies
In this article, Sino Biological demonstrates how Chimeric Antigen Receptors (CARs) can be utilized in novel cancer therapies, a change from the usual application of CARs, which heavily feature T-cells.